Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Dte Energy Dtg Stock Stabilizing Price At 16.60 Up 0.24 20260406 Is Chemomab Cmmb Stock Good For Beginners Price At 1.70 Up 0.89 20260408 Is Niagen Bioscience Nage Stock Moving Higher Price At 4.47 Up 2.05 20260406 Will Dt Cloudstar Dtsq Stock Outperform Peers Price At 11.15 Down 0.27 20260406 Is Sana Biotechnology Sana Stock Consolidating Price At 3.31 Up 3.59 20260406 Is Gambling.Com Gamb Stock Slowing Down Price At 3.85 Up 0.92 20260406 Could A Short Squeeze Happen In Mink Therapeutics Inkt Stock Inkt Q4 Earnings Beats Estimates By 0.28 20260408 1 Should I Buy Expensify Exfy Stock Now Exfy Q4 2025 Earnings Expensify Inc. Misses Eps Estimates No Revenue Disclosed 20260413 1 Can Jet.Ai Jtai Stock Increase Dividends Price At 6.21 Down 19.35 20260408 Netflix Inc NFLX Acquires AI Production Startup InterPositive to Drive Content Cost Efficiencies and Margin Expansion How Civista CIVB sensitive is to interest rates Q1 2026 Profit Surprises Wells Fargo Co WFC Maintains Neutral Stance on Thomson Reuters TRI Amid Mixed Analyst Target Adjustments and AI Sentiment Volatility PFX PhenixFIN Corporation reports sharp Q1 2026 EPS miss even as shares rise 039 percent in todays trading Is First FRMEP stock showing technical strength First posts 89 EPS beat outperforming analyst estimates FBIOP Fortress reports wider than expected Q4 2025 loss even as shares gain 626 percent today Invesco QQQ Trust QQQ Positioned for PostIPO SpaceX Inclusion Amid Historic Space ETF Inflow Surge Is HighTrend HTCO a value trap or a value play Craters 20260508 VHUB VenHub Global cites strong smart retail pilot traction in its newly released quarterly earnings report AG 1st Majestic Q4 2025 EPS far outpaces analyst estimates but shares dip 144 percent today Lam Research LRCX Sector Semiconductor Selloff Drives 34 Intraday Decline Amid AI Spending and Geopolitical Headwinds GLMD Galmed Pharmaceuticals shares rise 177 percent today despite reporting a wider than expected Q4 2025 loss per share